SDIC Fund Management Venture Capital Profile
SDIC Fund Management Company Ltd. is an independent private equity fund manager established in Aug. 2009. We currently advise and manage over RMB 50 billion of capital. The limited partners include a wide range of institutional investors across China.
ChinesestatefundinvestsingenefirmBGI-
The Central SOE Poverty Area Industrial Investment Fund, which is managed by SDIC Chuangyi, the wholly owned venture capital subsidiary of SDIC, paid 200 million renminbi ($30.8 million) for 1.4 million shares in BGI Genomics, a spokesman for SDIC
Venture Capital, Private Equity and M&A Database
Venture Capital Status Active Investments 2 Exits 1 Jiashan SDIC General Information Description Jiashan SDIC is a state-owned venture capital firm based in Jiaxing, China. Contact Information Investor Status Actively Seeking New Investments Primary Investor
TransThera Biosciences closes Series C round led by CMG …
· On July 22, TransThera Biosciences announced the completion of a Series C round led by CMG-SDIC Fund. The round also saw participation from Oceanpine Healthcare Fund, SDIC Venture Capital, Nanjing Fengling Investment, Ennovation Ventures, Eastern Handson, and existing investors Golden Partners Capital and Grand Yangtze Capital.
SDIC Fund Management Co
SDIC Fund Management Co | 587 followers on LinkedIn. SDIC Fund Management Co., Ltd established in 2009, is a leading fund management company focusing on private equity
Investors
Aucta has gained support from a dedicated group of investors including both global and China-based healthcare funds: Advantech, Cowin venture, Sangel, Grand Yangtze Capital, SDIC Venture Capital, etc.. Our investors are committed to support Aucta in becoming a significant specialty pharma player in both U.S. and China market place.
Biocytogen Stock / Share Price, Funding Rounds, …
Founding Date 2009 Biocytogen total Funding $284.3 m Biocytogen latest funding size $142 m Time since last funding 7 months ago Biocytogen investors Oriza Holdings, 3E Bioventures, SDIC Venture Capital, Cowin Capital, China Merchant Bank, SDIC VC Management, China Life Healthcare Fund, Cmb International, PICC Capital, SDIC Ventures, China Life Equity, Baifu Capital
AstraZeneca and Chinese Future Industry Investment …
SDIC Fund Management Company (SDIC Fund) is an independent private equity fund manager established in August 2009. It currently advises and manages more than RMB 60 billion of capital. The Future Industry Investment Fund is one of the funds that are managed by SDIC Fund.
Biocytogen Company Profile
Founding Date 2009 Biocytogen total Funding $284.3 m Biocytogen latest funding size $142 m Time since last funding 7 months ago Biocytogen investors Oriza Holdings, 3E Bioventures, SDIC Venture Capital, Cowin Capital, China Merchant Bank, SDIC VC Management, China Life Healthcare Fund, Cmb International, PICC Capital, SDIC Ventures, China Life Equity, Baifu Capital
These are the Top Venture Capital Companies in China …
Since its establishment, the project financing on the venture capital platform has exceeded 6.2 billion yuan, generating 407 financing projects, 323 seed/angel projects, 66 A-round projects, 15 B-round projects, 2 C-round projects and 1 M&A project Venture
KBP Biosciences appoints Brian McVeigh as CEO along …
The financing was co-led by Advantech Capital and SDIC Venture Capital, with participation from Sangel Capital, Ping An Ventures, Bay City Capital GF XINDE Life Science Investment Fund, Efung Capital, CASH Capital, Cowin Capital Group, Korea Investment
KBP完成7600萬美元A輪融資_新浪醫藥新聞
本輪融資由尚珹資本（Advantech Capital）和國投創業（SDIC Venture Capital）共同領投，Bay City Capital GF XINDE Life Science Investment Fund，倚鋒創投（Efung Capital），仙瞳資本（Sangel Capital），國科嘉
Our Company_KBP BIOSCIENCES
At KBP Biosciences we are dedicated to push the boundaries of science to transform the lives patients around the world. We are dedicated to delivering value to our communities, our employees, and the environment. We are responsible for our actions on people
Well-HealthcareTechnology closes multimillion-yuan …
· This investment was led by SDIC Venture Capital, with participation from Seeking Investment, LiYuan Venture Capital and Huadan Capital. To date, Bolean Technology has completed three rounds of financing. Industrial 2020-06-14 GreeNet closes RMB150m
Chinese state fund invests in gene firm BGI
· The Central SOE Poverty Area Industrial Investment Fund, which is managed by SDIC Chuangyi, the wholly owned venture capital subsidiary of SDIC, paid 200 million renminbi ($30.8 million) for 1.4 million shares in BGI Genomics, a spokesman for SDIC
，平安創新投資基金（Ping An Ventures）